/
DCF Valuation
Base-case fair value
$11.31
Intrinsic $15.08 · 25% MOS
Current price: $22.44
Base-case summary
Our base-case DCF for Sanara MedTech Inc. (SMTI) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 56.1% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $3M in trailing free cash flow, this produces an intrinsic value of $15.08 per share. A 25% safety margin gives a fair value of $11.31, suggesting the stock is currently 50% overvalued against the $22.44 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$3M
Cash & equivalents
$14M
Total debt
$48M
Shares outstanding
9M